CBNK insider update: Former CFO reports 3,400-share sale at $27.95
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Capital Bancorp (CBNK) insider filing reports that the former EVP and CFO sold 3,400 shares of common stock at $27.95 on 11/12/2025.
Following the sale, the reporting person beneficially owned 1,434 shares directly. He also holds 500 stock options with a $21.57 exercise price, exercisable on 07/15/2025 and expiring on 07/15/2029. A footnote states that of an original 2,000 options, 1,500 were forfeited upon resignation on 10/27/2025, leaving 500 vested.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 3,400 shares ($95,030)
Net Sell
2 txns
Insider
Canuso Dominic C
Role
Insider
Sold
3,400 shs ($95K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 3,400 | $27.95 | $95K |
| holding | Stock Options | -- | -- | -- |
Holdings After Transaction:
Common Stock — 1,434 shares (Direct);
Stock Options — 500 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What did CBNK’s former CFO report in this Form 4?
A sale of 3,400 shares of Capital Bancorp common stock at $27.95 on 11/12/2025.
What derivative securities are reported for CBNK (CBNK)?
He holds 500 stock options with a $21.57 exercise price, exercisable 07/15/2025 and expiring 07/15/2029.
Were any options forfeited by the former CFO of CBNK?
Yes. The note states 1,500 options from an original 2,000 were forfeited upon resignation on 10/27/2025.
What is the reporting person’s relationship to CBNK?
Listed as Former EVP, CFO and filing as one reporting person.
Was the transaction under a Rule 10b5-1 plan?
The form includes the 10b5-1 checkbox language; the excerpt does not indicate it was checked.